Browsing by Subject "rFVIIa"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events(Wiley Blackwell (John Wiley & Sons), 2014-11) Sozio, Margaret S.; Chalasani, Naga; Department of Medicine, IU School of Medicine